78
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]

Page 73 | Published online: 10 Mar 2020
This article refers to:
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

Wang HH, Lee HM, Raja V, et al. J Exp Pharmacol. 2019;11:1–14.

On page 13 the disclosure section should be presented as follows:

Disclosure

LMG is listed as an inventor on several related patents and these have been fully assigned to his institution, Stony Brook University, The State University of New York (SUNY). FJ is also listed as an inventor on several related patents which have been fully assigned to Stony Brook University and to Chem-Master Int. Inc. on a shared basis. In addition, both LMG and FJ are minor shareholders in Traverse BioSciences, Inc., and JS is president and major shareholder in Traverse. All other authors declare that there are no conflicts of interest regarding the publication of this paper.

The authors apologize for this error.